Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): The importance of smoking history, socioeconomic and marital statuses, and ethnicity

Journal of Thoracic Oncology

Volumn 4, Issue 1, 2009, Pages 37-43

  Ou, Sai Hong Ignatius ^a,b   Ziogas, Argyrios ^b,c   Zell, Jason A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asian ethnicity; California Cancer Registry; Extensive stage small cell lung cancer (ED SCLC); Female gender; Marital status; Prognostic factors; Smoking status; Socioeconomic status

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; HAZARD RATIO; HISPANIC; HUMAN; INFANT; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; UNITED STATES; UNIVARIATE ANALYSIS; CANCER STAGING; ETHNIC GROUP; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; SOCIAL CLASS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; MALE; MARITAL STATUS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SMOKING; SOCIAL CLASS; SURVIVAL RATE; YOUNG ADULT;

EID: 61549098710     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31819140fb     Document Type: Article

References (37)

1. Parkin DM, Bray FJ, Ferlay L, Pissani P. Global cancer statistics. CA Cancer J Clin 2002;55:74-108.
2. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the 30 years: analysis of the Surveillance, Epidemiology, and End Results database. J Clin Oncol 2006;24:4539-4544.
3. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31:139-148.
4. Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006; 24:2245-2251.
5. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - a different disease. Nature 2007;7:778-790.
6. Subramanian J, Govindan R. Lung cancer in never-smokers: a review. J Clin Oncol 2007;25:561-570.
7. Ou S-HI, Ziogas A, Zell JA. Epidemiology study of never-smokers with non-small cell lung cancer (NSCLC): high percentages of Asian and Hispanic female never-smokers and the significance of Asian ethnicity. J Clin Oncol 2008;26 (May 20 suppl; abstr 8004).
8. Zell JA, Ou S-HI, Ziogas A, Anton-Culver H. Epidemiology of bron-chioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2005;23:8396-8405.
9. International classification of diseases for oncology (ICD-O). In A Fritz, et al. (Eds.), 3rd Ed. Geneva: World Health Organization, 2000.
10. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-711.
11. Wolf M, Holle R, Hans K, Drings P, Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor of survival. Br J Cancer 1991;63:986-992.
12. Mohan A, Goyal A, Singh S, et al. Survival in small cell lung cancer in India: prognostic utility of clinical features, laboratory parameters and response to treatment. Indian J Cancer 2006;43:67-74.
13. Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration Lung Cancer Study Group versus International Association for the Study of Lung Cancer-what limits limited disease. Lung Cancer 2002;37:271-276.
14. Perng RP, Chen CY, Chang GC, et al. Revisit of 1997 TNM staging system-survival analysis of 1112 lung cancer patients in Taiwan. Jpn J Clin Oncol 2007;37:9-15.
15. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years-an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13:1215-1220.
16. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nature Rev Cancer 2003;3:733-744.
17. Albain KS, Crowley JJ, Leblanc M, Livingston R. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-patient Southwest oncology group data base. JClin Oncol 1990;8:1563-1574.
18. Blackstock AW, Herdon II JE, Paskett ED, et al. Similar outcomes between African-American and non-African American patients with extensive-stage small cell lung carcinoma: report from the Cancer and Leukemia Group B. J Clin Oncol 2006;24:407-412.
19. Ou S-HI, Zell JA, Ziogas A, Anton-Culver H. Low socioeconomic status is a poor prognostic factor for survival in stage I non-small-cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008;112:2011-2020.
20. Toh CK, Hee SW, Lim WT, et al. Survival of small-cell lung cancer and its determinants of outcome in Singapore. Ann Acad Med Singapore 2007;36:181-188.
21. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
22. Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer. J Clinc Oncol 2006;24:2038-2043.
23. Natalie RB, Lara PN, Chansky K, et al. S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC). J Clin Oncol 2008;26:(May 20 suppl: abstract 7512).
24. Beutler E, Gelbert T, Demina A. Racial variability in the UDP-glucu- ronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism. Proc Natl Acad Sci U S A 1998;95: 8170-8174.
25. Undevia SD, Gomez-Abuin G, Ratain MJ. Pharmacokinetic variability of anticancer agents. Nature Rev Cancer 2005;5:447-458.
26. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1521 patients. J Clin Oncol 1989;7:344-345.
27. Albain KS, Crowley JJ, Livingston RB. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest 1991;99:1425-1432.
28. Osterlind K, Hansen HH, Hansen M, Dombernowsky P, Andersen PK. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 1986;4:1307-1313.
29. Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986;46:4189-4194.
30. Paesmans M, Sculier P, Lecomte J, et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 2000;89:523-533.
31. Bremnes RM, Sundstrom S, Aasebo U, et al. The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 years follow-up. Lung Cancer 2003;39:303-313.
32. Singh S, Parulekar W, Murray N, et al. Influence of sex and toxicity and treatment outcome in small cell lung cancer. J Clin Oncol 2005;43:850-856.
33. Christodolou C, Pavlidis N, Samantas E, et al. Prognostic factors in Greek patients with small lung cancer (SCLC). A Hellenic cooperative oncology group study. Anticancer Res 2002;22:3749-3757.
34. Sagman U, Feld R, Evans WK, et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol 1991;9:954-961.
35. Sagman U, Maki E, Evans WK, et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 1991;9:1639- 1649.
36. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic Cranial Irradiation Overview Collaboration Group. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Eng J Med 1999;341:476-484.
37. Slotman B, Faivre-Finn C, Kramer G, et al. EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Eng J Med 2007;357:664-672.